{
  "trial_id": "NCT00001457",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "53 years old"
    },
    {
      "criterion": "Sex",
      "label": "met",
      "evidence": "male"
    },
    {
      "criterion": "HBsAg in serum for at least 6 months",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Liver biopsy histology showing chronic hepatitis with or without cirrhosis",
      "label": "met",
      "evidence": "chronic inflammation compatible with a chronic viral hepatitis"
    },
    {
      "criterion": "Previous therapy with alpha interferon without a lasting effect or intolerance to alpha interferon, due to side effects",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Written informed consent",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Group A: Absence of HBeAg from serum despite elevations in serum aminotransferases",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Group B: Proteinuria of greater than 1 gm per 24 hours for patients with glomerulonephritis",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Group C: Anti-HDV in serum and HDV antigen in liver biopsy or HDV RNA in serum and elevations in serum aminotransferases",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Group D: HBeAg and HBV DNA in serum but ineligibility to enter the multicenter trial of lamivudine",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnant or if capable of bearing or fathering children must practice adequate contraception",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Significant systemic illnesses other than liver diseases, including congestive heart failure, renal failure, chronic pancreatitis, diabetes mellitus with poor control",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Pre-existing bone marrow compromise: hematocrit must be greater than 30%, white blood cell count must be greater than 2000 mm(3), platelets must be greater than 70,000 mm(3)",
      "label": "not_met",
      "evidence": "hematocrit not specified"
    },
    {
      "criterion": "Creatinine clearance must be greater than 50 cc/min",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "A history of clinically apparent pancreatitis or evidence of subclinically pancreatitis as shown by serum amylase values twice the upper limits of the normal range and abnormalities of the pancreas on computerized tomography or other imaging studies of the abdomen",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Irreversibly severe cirrhosis as defined by Child's stage C",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Presence of anti-HIV or anti-HCV with HCV RNA in serum",
      "label": "not_met",
      "evidence": "HCV infection"
    },
    {
      "criterion": "Immunosuppressive therapy requiring use of more than 10 mg of prednisone (or its equivalent) per day",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Other antiviral therapy for chronic hepatitis B within the previous 3 months",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "Patient has chronic HCV infection, but no evidence of other significant systemic illnesses or pre-existing bone marrow compromise. He is on IFN and RBV combination therapy with direct antiviral drugs.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT00001457",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}